Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Oxymetazoline for bronchoscopy in patients with turbinate hypertrophy
ChiCTR2300077642Phase 4Not yet recruiting
- Sponsor
- Chaohu Hospital of Anhui Medical University
- Start
- Nov 2023
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised trial of oxymetazoline in Turbinate hypertrophy (3 arms), sponsored by Chaohu Hospital of Anhui Medical University. Primary endpoint: Tracheoscopic arrival time at the vocal folds. Planned start Nov 2023; status: not yet recruiting.
02
Drugs
oxymetazoline
03
Conditions
Turbinate hypertrophy
Beyond the preview
Go deeper on ChiCTR2300077642.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2300077642.